FDA Inspection 1170388 — Mark D. Akin, MD
The FDA completed an inspection of Mark D. Akin, MD on May 18, 2022 in Austin, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 18, 2022
- Fiscal Year
- 2022
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Austin, TX (United States)
Additional Details
Clinical Investigator (CI)